Initially characterized as primarily a respiratory illness, Covid-19's entry into the body was linked to ACE2 receptors, which are highly expressed in lung tissue. However, as our understanding of the disease evolved, it became clear that Covid-19 has a systemic impact, affecting nearly all organ systems, with a notable predilection for the vascular system. Beyond the lungs, ACE2 receptors are also abundantly found in endothelial cells, which form the inner lining of all blood vessels. Infection of these cells by the virus can result in widespread vascular injury. Moreover, the Covid-19 virus is known to directly infect myocardial cells and pericytes surrounding them. Consequently, individuals post-Covid-19 infection can exhibit significant myocardial damage and vascular abnormalities. Research suggests that myocardial involvement can be observed in approximately 75% of cases, even in patients without overt cardiac symptoms. For patients with pre-existing coronary artery disease, the heightened vascular inflammation and damage induced by Covid-19 can destabilize even non-critical atherosclerotic plaques, potentially leading to acute plaque rupture, vessel occlusion, and myocardial infarction.